
Alert: Major Price Decline (3/18/25)-Catalyst Biosciences Inc (NASDAQ: GYRE).
Catalyst Biosciences Inc (NASDAQ: GYRE) stock closed at $8.57 on 3/18/25 after a major decline of -30.2%. Moreover, trading volume in this decline was exceptionally high at 812% of normal. The stock has declined -17.0% […]